GIST

>

Latest News

Highlighting Recent Changes and Recommendations for the Treatment of GIST
Highlighting Recent Changes and Recommendations for the Treatment of GIST

March 27th 2023

In an interview, Edwin Choy, MD, discussed the treatment landscape of GIST and recent changes to NCCN guidelines.

Phase 3 Study Evaluates Ripretinib for KIT Exon 11-Mutated GIST
Phase 3 Study Evaluates Ripretinib for KIT Exon 11-Mutated GIST

March 21st 2023

Ripretinib Recognized by FDA and NCCN for Treatment of Second-Line GIST
Ripretinib Recognized by FDA and NCCN for Treatment of Second-Line GIST

March 15th 2023

Targeted Therapies Begin to Transform the Treatment of Sarcomas
Targeted Therapies Begin to Transform the Treatment of Sarcomas

February 3rd 2023

ctDNA Analysis Appears Essential for Predicting Treatment Response in Advanced KIT-Mutant GIST
ctDNA Analysis Appears Essential for Predicting Treatment Response in Advanced KIT-Mutant GIST

January 25th 2023

Video Series
Video Interviews

More News